Patent · US Expired

Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods

US6610697B1 · kind B1 · utility

2Cited by
1References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 2000
Grant dateAug 26, 2003
Priority date
Expiry dateOct 27, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a series of imidazopyrimidines of Formula I, and pharmaceutical compositions containing them. The compounds of the invention inhibit the production of a number of inflammatory cytokines and are useful in the treatment and prevention of diseases associated with the overproduction thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.